Eli Lilly is discontinuing development of its Alzheimer’s drug candidate mevidalen. The decision follows a phase II trial ...

AstraZeneca beat market expectations in the third quarter. At the same time, the company announced a cost-cutting programme ...

Ahead of its annual general meeting in May 2027, Sobi's nomination committee has announced its proposed new chair. The ...

SynAct Pharma has entered into its first commercial partnership for resomelagon as a potential treatment for dengue fever.

Ferring has signed an agreement to acquire US biotechnology company Gameto in a deal worth up to $1.4 billion.

MEMBER ANNOUNCEMENT - New welding solution aims to increase capacity and ensure quality in flip-off cap production ...

The Danish drug manufacturer Genmab has announced the results of the current Phase 2 trials for treatment of both colorectal ...

A single tumour DNA molecule among more than a million others. That is how small a trace of cancer Abbott’s upgraded ...

US biotech company Artiva Biotherapeutics is discontinuing the development of a cell therapy for autoimmune diseases and laying off 94 per cent of its workforce after two patients died during a ...

Medical breakthroughs have transformed healthcare, but scientific progress alone is not enough. As misinformation spreads and trust in science comes under pressure, how can we ensure that healthcare ...

Danish biotech company ResoTher Pharma, which is developing drugs to treat heart conditions, plans to list on the Swedish ...

AstraZeneca is considering developing cancer vaccines based on mRNA technology, CEO Pascal Soriot said at a conference on Tuesday, Bloomberg News reports.